MVA-BN-Filo(Bavarian Nordic, Crucell)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameMVA-BN-Filo(Bavarian Nordic, Crucell)
Drug Alias NameMvabea
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsHemorrhagic Fever, Ebola
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2020/07/01
Country/TerritoryUnited StatesUgandaCongo, The Democratic Republic of the +[4
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Other Information

ATC CodeJ07BX
Related LinksWikipedia